Relieves allergy effectively without sedation.
Composition
Levocetirizine 2.5mg. + Montelukast 4mg.
| LEVOCETIRIZINE HYDROCHLORIDE I.P. 5 mg. |
| MONTELUKAST SODIUM I.P. 10mg |
Indications:
- Seasonal Rhinitis
- Bronchial asthma
- Allergic Rhinitis
Benefits:
Levocetirizine –
- Selection long acting Peripharal H1 receptor antagonist/antihistamine It has less sedative effect.
Montelukast –
- It is a competitive leukotrine Antagonist It inhibits bronchoconstriction by attaching LTD 4 receptor to LTD Reecptor.